1 Study Coverage
    1.1 PARP Inhibitor Biomarkers Testing Product Product Introduction
    1.2 Market by Type
        1.2.1 Global PARP Inhibitor Biomarkers Testing Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Testing Kits
        1.2.3 Testing Assays
    1.3 Market by Application
        1.3.1 Global PARP Inhibitor Biomarkers Testing Product Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global PARP Inhibitor Biomarkers Testing Product Sales Estimates and Forecasts 2017-2028
    2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Estimates and Forecasts 2017-2028
    2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global PARP Inhibitor Biomarkers Testing Product Sales by Region
        2.4.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022)
        2.4.2 Global Sales PARP Inhibitor Biomarkers Testing Product by Region (2023-2028)
    2.5 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region
        2.5.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022)
        2.5.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Manufacturers
        3.1.1 Global Top PARP Inhibitor Biomarkers Testing Product Manufacturers by Sales (2017-2022)
        3.1.2 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PARP Inhibitor Biomarkers Testing Product in 2021
    3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Manufacturers
        3.2.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Manufacturers (2017-2022)
        3.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Testing Product Revenue in 2021
    3.3 Global PARP Inhibitor Biomarkers Testing Product Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global PARP Inhibitor Biomarkers Testing Product Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Type
        4.1.1 Global PARP Inhibitor Biomarkers Testing Product Historical Sales by Type (2017-2022)
        4.1.2 Global PARP Inhibitor Biomarkers Testing Product Forecasted Sales by Type (2023-2028)
        4.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    4.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type
        4.2.1 Global PARP Inhibitor Biomarkers Testing Product Historical Revenue by Type (2017-2022)
        4.2.2 Global PARP Inhibitor Biomarkers Testing Product Forecasted Revenue by Type (2023-2028)
        4.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    4.3 Global PARP Inhibitor Biomarkers Testing Product Price by Type
        4.3.1 Global PARP Inhibitor Biomarkers Testing Product Price by Type (2017-2022)
        4.3.2 Global PARP Inhibitor Biomarkers Testing Product Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Application
        5.1.1 Global PARP Inhibitor Biomarkers Testing Product Historical Sales by Application (2017-2022)
        5.1.2 Global PARP Inhibitor Biomarkers Testing Product Forecasted Sales by Application (2023-2028)
        5.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    5.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application
        5.2.1 Global PARP Inhibitor Biomarkers Testing Product Historical Revenue by Application (2017-2022)
        5.2.2 Global PARP Inhibitor Biomarkers Testing Product Forecasted Revenue by Application (2023-2028)
        5.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    5.3 Global PARP Inhibitor Biomarkers Testing Product Price by Application
        5.3.1 Global PARP Inhibitor Biomarkers Testing Product Price by Application (2017-2022)
        5.3.2 Global PARP Inhibitor Biomarkers Testing Product Price Forecast by Application (2023-2028)
6 North America
    6.1 North America PARP Inhibitor Biomarkers Testing Product Market Size by Type
        6.1.1 North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
        6.1.2 North America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
    6.2 North America PARP Inhibitor Biomarkers Testing Product Market Size by Application
        6.2.1 North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
        6.2.2 North America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
    6.3 North America PARP Inhibitor Biomarkers Testing Product Market Size by Country
        6.3.1 North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2028)
        6.3.2 North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Type
        7.1.1 Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
        7.1.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
    7.2 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Application
        7.2.1 Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
        7.2.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
    7.3 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Country
        7.3.1 Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2028)
        7.3.2 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Type
        8.1.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
        8.1.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
    8.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Application
        8.2.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
        8.2.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
    8.3 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Region
        8.3.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2028)
        8.3.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Type
        9.1.1 Latin America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
        9.1.2 Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
    9.2 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Application
        9.2.1 Latin America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
        9.2.2 Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
    9.3 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Country
        9.3.1 Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2028)
        9.3.2 Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Type
        10.1.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2028)
        10.1.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2028)
    10.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Application
        10.2.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2028)
        10.2.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2028)
    10.3 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Country
        10.3.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2028)
        10.3.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Myriad Genetics, Inc.
        11.1.1 Myriad Genetics, Inc. Corporation Information
        11.1.2 Myriad Genetics, Inc. Overview
        11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Myriad Genetics, Inc. Recent Developments
    11.2 Hoffmann-La Roche AG
        11.2.1 Hoffmann-La Roche AG Corporation Information
        11.2.2 Hoffmann-La Roche AG Overview
        11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Hoffmann-La Roche AG Recent Developments
    11.3 Invitae Corporation
        11.3.1 Invitae Corporation Corporation Information
        11.3.2 Invitae Corporation Overview
        11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Invitae Corporation Recent Developments
    11.4 NeoGenomics Laboratories, Inc.
        11.4.1 NeoGenomics Laboratories, Inc. Corporation Information
        11.4.2 NeoGenomics Laboratories, Inc. Overview
        11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 NeoGenomics Laboratories, Inc. Recent Developments
    11.5 BPS Bioscience, Inc.
        11.5.1 BPS Bioscience, Inc. Corporation Information
        11.5.2 BPS Bioscience, Inc. Overview
        11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 BPS Bioscience, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 PARP Inhibitor Biomarkers Testing Product Industry Chain Analysis
    12.2 PARP Inhibitor Biomarkers Testing Product Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 PARP Inhibitor Biomarkers Testing Product Production Mode & Process
    12.4 PARP Inhibitor Biomarkers Testing Product Sales and Marketing
        12.4.1 PARP Inhibitor Biomarkers Testing Product Sales Channels
        12.4.2 PARP Inhibitor Biomarkers Testing Product Distributors
    12.5 PARP Inhibitor Biomarkers Testing Product Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 PARP Inhibitor Biomarkers Testing Product Industry Trends
    13.2 PARP Inhibitor Biomarkers Testing Product Market Drivers
    13.3 PARP Inhibitor Biomarkers Testing Product Market Challenges
    13.4 PARP Inhibitor Biomarkers Testing Product Market Restraints
14 Key Findings in The Global PARP Inhibitor Biomarkers Testing Product Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global PARP Inhibitor Biomarkers Testing Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Testing Kits
    Table 3. Major Manufacturers of Testing Assays
    Table 4. Global PARP Inhibitor Biomarkers Testing Product Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022) & (K Units)
    Table 7. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2022)
    Table 8. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2023-2028) & (K Units)
    Table 9. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2023-2028)
    Table 10. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2017-2022)
    Table 12. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2023-2028)
    Table 14. Global PARP Inhibitor Biomarkers Testing Product Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Manufacturers (2017-2022)
    Table 16. Global PARP Inhibitor Biomarkers Testing Product Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Manufacturers (2017-2022)
    Table 18. PARP Inhibitor Biomarkers Testing Product Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global PARP Inhibitor Biomarkers Testing Product Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global PARP Inhibitor Biomarkers Testing Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Testing Product as of 2021)
    Table 21. PARP Inhibitor Biomarkers Testing Product Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers PARP Inhibitor Biomarkers Testing Product Product Offered
    Table 23. Date of Manufacturers Enter into PARP Inhibitor Biomarkers Testing Product Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 26. Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 27. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Type (2017-2022)
    Table 28. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Type (2023-2028)
    Table 29. Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2017-2022)
    Table 32. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Type (2023-2028)
    Table 33. PARP Inhibitor Biomarkers Testing Product Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global PARP Inhibitor Biomarkers Testing Product Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 36. Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 37. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Application (2017-2022)
    Table 38. Global PARP Inhibitor Biomarkers Testing Product Sales Share by Application (2023-2028)
    Table 39. Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Application (2017-2022)
    Table 42. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Application (2023-2028)
    Table 43. PARP Inhibitor Biomarkers Testing Product Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global PARP Inhibitor Biomarkers Testing Product Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 46. North America PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 47. North America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 50. North America PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 51. North America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
    Table 54. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
    Table 55. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 58. Europe PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 59. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 62. Europe PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 63. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
    Table 66. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
    Table 67. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Myriad Genetics, Inc. Corporation Information
    Table 106. Myriad Genetics, Inc. Description and Major Businesses
    Table 107. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Myriad Genetics, Inc. Recent Developments
    Table 110. Hoffmann-La Roche AG Corporation Information
    Table 111. Hoffmann-La Roche AG Description and Major Businesses
    Table 112. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Hoffmann-La Roche AG Recent Developments
    Table 115. Invitae Corporation Corporation Information
    Table 116. Invitae Corporation Description and Major Businesses
    Table 117. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Invitae Corporation Recent Developments
    Table 120. NeoGenomics Laboratories, Inc. Corporation Information
    Table 121. NeoGenomics Laboratories, Inc. Description and Major Businesses
    Table 122. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. NeoGenomics Laboratories, Inc. Recent Developments
    Table 125. BPS Bioscience, Inc. Corporation Information
    Table 126. BPS Bioscience, Inc. Description and Major Businesses
    Table 127. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. BPS Bioscience, Inc. Recent Developments
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. PARP Inhibitor Biomarkers Testing Product Distributors List
    Table 133. PARP Inhibitor Biomarkers Testing Product Customers List
    Table 134. PARP Inhibitor Biomarkers Testing Product Market Trends
    Table 135. PARP Inhibitor Biomarkers Testing Product Market Drivers
    Table 136. PARP Inhibitor Biomarkers Testing Product Market Challenges
    Table 137. PARP Inhibitor Biomarkers Testing Product Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. PARP Inhibitor Biomarkers Testing Product Product Picture
    Figure 3. Global PARP Inhibitor Biomarkers Testing Product Market Share by Type in 2021 & 2028
    Figure 3. Testing Kits Product Picture
    Figure 4. Testing Assays Product Picture
    Figure 5. Global PARP Inhibitor Biomarkers Testing Product Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Others
    Figure 9. PARP Inhibitor Biomarkers Testing Product Report Years Considered
    Figure 10. Global PARP Inhibitor Biomarkers Testing Product Sales 2017-2028 (K Units)
    Figure 11. Global PARP Inhibitor Biomarkers Testing Product Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global PARP Inhibitor Biomarkers Testing Product Revenue 2017-2028 (US$ Million)
    Figure 13. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2017-2022)
    Figure 15. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2023-2028)
    Figure 16. North America PARP Inhibitor Biomarkers Testing Product Sales YoY (2017-2028) & (K Units)
    Figure 17. North America PARP Inhibitor Biomarkers Testing Product Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe PARP Inhibitor Biomarkers Testing Product Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe PARP Inhibitor Biomarkers Testing Product Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific PARP Inhibitor Biomarkers Testing Product Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America PARP Inhibitor Biomarkers Testing Product Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America PARP Inhibitor Biomarkers Testing Product Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The PARP Inhibitor Biomarkers Testing Product Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of PARP Inhibitor Biomarkers Testing Product in the World: Market Share by PARP Inhibitor Biomarkers Testing Product Revenue in 2021
    Figure 28. Global PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 30. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 31. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 32. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 33. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 34. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 35. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 36. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 37. North America PARP Inhibitor Biomarkers Testing Product Sales Share by Country (2017-2028)
    Figure 38. North America PARP Inhibitor Biomarkers Testing Product Revenue Share by Country (2017-2028)
    Figure 39. U.S. PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 42. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 43. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 44. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 45. Europe PARP Inhibitor Biomarkers Testing Product Sales Share by Country (2017-2028)
    Figure 46. Europe PARP Inhibitor Biomarkers Testing Product Revenue Share by Country (2017-2028)
    Figure 47. Germany PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 48. France PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue Share by Region (2017-2028)
    Figure 58. China PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 61. India PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 69. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 71. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America PARP Inhibitor Biomarkers Testing Product Sales Share by Country (2017-2028)
    Figure 73. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Share by Country (2017-2028)
    Figure 74. Mexico PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue Share by Country (2017-2028)
    Figure 83. Turkey PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE PARP Inhibitor Biomarkers Testing Product Revenue (2017-2028) & (US$ Million)
    Figure 86. PARP Inhibitor Biomarkers Testing Product Value Chain
    Figure 87. PARP Inhibitor Biomarkers Testing Product Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed